Travere Therapeutics
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.preventcystinestones.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Travere Therapeutics
Travere Therapeutics, Inc. is a pharmaceutical company focused on the treatment of cystinuria, a rare genetic disorder that causes the continuous buildup of cystine in the urine and the formation of cystine kidney stones. The company provides educational resources and information on disease management for patients and families, including guidance on therapeutic lifestyle changes, the use of cystine-binding thiol drugs, and the importance of monitoring urinary cystine levels. Its efforts target individuals with this autosomal recessive disorder to help them reduce the risk of stone formation and avoid long-term kidney damage.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Travere Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Travere Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Travere Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Travere Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Travere Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Travere Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Travere Therapeutics launches new products
Check out if Travere Therapeutics is spiking on competitors!
Check if Travere Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Travere Therapeutics
Compare insights from companies similar to Travere Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Travere Therapeutics
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Travere Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Travere Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Travere Therapeutics.
Travere Therapeutics Tech Stack
A closer look at the technologies used by Travere Therapeutics
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Travere Therapeutics
Sign Up For FreeTo access detailed company insights
Travere Therapeutics, Inc. is a pharmaceutical company focused on the treatment of cystinuria, a rare genetic disorder that causes the continuous buildup of cystine in the urine and the formation of cystine kidney stones. The company provides educational resources and information on disease management for patients and families, including guidance o... Read More
